Transpek Industry Limited has secured the right to use the Responsible Care Logo for a three-year period starting July 2026, reinforcing its commitment to sustainability standards in the chemical sector. The certification, issued by the Indian Chemical Council, is valid until June 2029 and authorizes the company to display the logo as a mark of its adherence to responsible practices.

The Responsible Care initiative is a global voluntary effort aimed at improving the chemical industry's performance in health, safety, and environmental protection. By obtaining this certification, Transpek Industry aligns itself with these rigorous standards, which are monitored by the Indian Chemical Council.

The disclosure was made to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The certificate confirms the company's eligibility to use the logo, signifying its compliance with the council's guidelines for sustainable chemical management.

Transpek Industry Limited reported a 6.3% decline in Profit After Tax (PAT) to ₹45.6 crore for the financial year ended March 31, 2026 (FY26), while revenue from operations decreased by 4.8% to ₹645.7 crore. The company’s EBITDA for the year stood at ₹117.9 crore, with a margin of 18.3%, slightly lower than the 18.2% recorded in the previous year. For the fourth quarter (Q4 FY26), PAT fell sharply to ₹6.6 crore from ₹19.3 crore in Q4 FY25, and revenue dropped to ₹148.2 crore from ₹165.3 crore in the same period last year.

The company’s operational performance in Q4 FY26 reflected a contraction in profitability, with EBITDA declining by 44.9% to ₹22.0 crore compared to ₹40.0 crore in Q4 FY25. The EBITDA margin for the quarter stood at 14.4%. Total expenses for the quarter included cost of materials consumed at ₹62.2 crore and employee expenses at ₹17.6 crore. Finance costs for the full year reduced to ₹8.1 crore from ₹11.7 crore in FY25, contributing to a stable profit before tax figure of ₹61.2 crore.

Consolidated Financial Performance

The following table outlines the key financial metrics for Transpek Industry Limited for Q4 FY26, Q3 FY26, and the full years FY26 and FY25:

On the balance sheet front, the company’s total assets stood at ₹1,008.3 crore as of March 26, 2026, up from ₹1,000.5 crore in the previous year. Total equity increased to ₹767.4 crore from ₹745.3 crore, driven by an increase in other equity. Borrowings decreased significantly, with total financial liabilities related to borrowings standing at ₹42.5 crore compared to ₹53.1 crore in the prior year. The company maintained a healthy cash position, with cash and cash equivalents rising to ₹57.8 crore from ₹56.5 crore.

Strategic Developments and Awards

Beyond the financial results, Transpek Industry highlighted its sustainability achievements, noting it was awarded the prestigious EcoVadis 'Gold Medal' for outstanding sustainability performance. This recognition ranks the company among the top 5% of all companies evaluated by EcoVadis in the Chemical Sector. The company also received several other accolades, including the CSR Award (Large Scale Category) at the 4th GEO Excellence Awards and the Vadodara Industrial Gaurav Award for Industry Working for Nation Building.

The company’s long-term supply agreement with a global chemical giant, which commenced in January 2018, continues to drive its global presence. Transpek operates multipurpose and multiproduct plants spread over 100 acres with a total production capacity of 66,000 MTPA. Its products are supplied to varied industries including pharmaceuticals, agrochemicals, polymers, and dyes, with a sales distribution that sees significant contributions from both international and domestic markets.